The 18th Annual Pain Therapeutics Summit is coming to Boston on October 28-29, 2024.


 October 19-20, 2023 | San Diego, CA

Identifying and Advancing Novel Pain Drugs Through Preclinical, Clinical Development and Commercialization

2017 Speaking Faculty (4)

Laura Bohn, Ph.D., Professor, Departments of Molecular Medicine & Neuroscience, The Scripps Research Institute
Laura Bohn, Ph.D., Professor, Departments of Molecular Medicine & Neuroscience, The Scripps Research Institute  
Nigel Calcutt, Ph.D., Professor, University of California San Diego, Co-Founder, WinSanTor
Allen Downs, CLP, Senior Corporate & Business Development Lead, Corporate & Business Development, Mundipharma International Limited
Jeffrey Dayno, MD, Chief Medical Officer, Egalet
Narender Gavva, Ph.D., Scientific Director, Amgen
Geert Jan Groeneveld, MD, Ph.D., Research Director, CNS, Centre for Human Drug Research
Tilo Grosser, MD, Research Associate Professor, Department of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania
Mary Hannaman, MD, President, Co-Founder, NeuroDigm
Sunyoung Kim, D.Phil., Founder and Chief Scientific Officer, ViroMed
D. Lynn Kirkpatrick, Ph.D., President and CEO, Ensysce Biosciences
Sanford J. Madigan, Ph.D., Chief Executive Officer, Sova Pharmaceuticals
Aashish Manglik, MD, Ph.D., Stanford Distinguished Fellow, Department of Molecular and Cellular Physiology, Stanford University School of Medicine
Daniel Mikol, MD, Ph.D., Executive Medical Director, Global Neuroscience Development, Amgen
Mikhail "Mike" Nemenov, Ph.D., Founder and Chief Scientist, LasMed LLC, Senior Research Scholar, Stanford University
Frank Rice, Ph.D., President and Chief Scientist, Integrated Tissue Dynamics
Bill Schmidt, Ph.D., President, Northstar Consulting
Neil Singla, MD, Chief Scientific Officer, Lotus Clinical Research
Randall Stevens, MD, Chief Medical Officer, Centrexion Therapeutics
Simon Tate, Ph.D., Chief Scientific Officer, Convergence Pharmaceuticals, Non-Executive Director, Biogen
Tanya Wallace, Ph.D., Head of Biology, Blackthorn Therapeutics
Mark Weinreb, MS, Chief Executive, President & Chairman, BioRestorative Therapies 

About Us

Arrowhead conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward.